| Issue |
Section |
Title |
File |
| Vol 16, No 1 (2019) |
Articles |
The role of ß2-adrenergic receptor gene polymorphisms in the pharmacological response to bronchial asthma therapy |
(Rus)
|
| Vol 15, No 6 (2018) |
Articles |
The modern view of the role of innate and adaptive immunity in bronchial asthma |
|
| Vol 15, No 4 (2018) |
Articles |
Federal Clinical Recommendations. Allergic rhinitis |
|
| Vol 15, No 4 (2018) |
Articles |
Class of leukotriene drugs in treatment of allergic rhinitis [Consensus document LIRA Leukotrienes and Allergic Rhinitis (LIRA, Leukotrienes Impact on Rhinitis Allergic)] |
|
| Vol 15, No 3 (2018) |
Articles |
Monoclonal antibodies in the treatment of bronchial asthma |
|
| Vol 15, No 1 (2018) |
Articles |
Bronchial asthma in combination with chronic rhinosinusitis with nasal polyps: epidemiology, prevalence and peculiarities of their relationship |
|
| Vol 15, No 1 (2018) |
Articles |
The efficiency of hypoallergenic space created with LG Puricare™ air purifier in the complex therapy of seasonal and perennial allergic rhinitis and bronchial asthma |
|
| Vol 14, No 4-5 (2017) |
Articles |
ACTUAL CONCEPTION OF ALLERGEN-SPECIFIC IMMUNOTHERAPY MECHANISMS, POTENTIAL BIOMARKERS OF EFFICACY AND WAYS OF ENHANCEMENT |
|
| Vol 14, No 4-5 (2017) |
Articles |
THE DIAGNOSTIC SIGNIFICANCE OF IMMUNOLOGICAL PARAMETERS OF THE PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
|
| Vol 14, No 4-5 (2017) |
Articles |
THE PLACE OF ANTILEUKOTRIENE MEDICATIONS IN ANTIINFLAMMATORY THERAPY OF BRONCHIAL ASTHMA |
|
| Vol 14, No 3 (2017) |
Articles |
Algorithm of biophenotyping and choice of medication for targeted therapy of severe uncontrolled asthma with eosinophilic type of airways inflammation |
|
| Vol 14, No 3 (2017) |
Articles |
ARIA 2016: Integrated care pathways for predictive medicine across the life cycle |
|
| Vol 14, No 3 (2017) |
Articles |
Principles of selecting therapy for patients with mild asthma. RAACI and RRO agreed recommendations |
|
| Vol 14, No 2 (2017) |
Articles |
Clinical contraindications to allergen immunotherapy |
|
| Vol 14, No 2 (2017) |
Articles |
Prospects for studying of FOXP3 and its isoforms expression in allergic diseases |
|
| Vol 14, No 1 (2017) |
Articles |
Allergen-specific immunotherapy. Analytic review of current international and Russian federal position papers |
|
| Vol 13, No 2 (2016) |
Articles |
Modern view on immunopathogenesis of asthma |
|
| Vol 13, No 4-5 (2016) |
Articles |
FEDERAL CLINICAL RECOMMENDATIONS. ALLERGEN-SPECIFIC IMMUNOTHERAPY |
|
| Vol 13, No 6 (2016) |
Articles |
Clinical efficacy of subcutaneous and sublingual allergen-specific immunotherapy of allergic rhinitis and conjunctivitis |
(Rus)
|
| Vol 12, No 6 (2015) |
Articles |
Intranasal steroids in treatment of allergic rhinitis |
|
| Vol 12, No 4 (2015) |
Articles |
Current strategies of allergen-specific immunotherapy |
|
| Vol 12, No 3 (2015) |
Articles |
Allergic rhinitis and allergic conjunctivitis: one disease - two clinical forms |
|
| Vol 12, No 5 (2015) |
Articles |
Immunobiological medicines in treatment of bronchial asthma: experience and prospects of application |
|
| Vol 12, No 2 (2015) |
Articles |
Changing the basic treatment as a way to achieve asthma control |
|
| Vol 11, No 3 (2014) |
Articles |
ALLERGY TODAY. ANALYSIS OF NEW EPIDEMIOLOGICAL DATA |
|
| Vol 11, No 2 (2014) |
Articles |
The influence of climatic factors on the spectrum and structure of allergic diseases in the case of the Moscow region |
|
| Vol 11, No 5 (2014) |
Articles |
BRONCHOLITIC THERAPY IN BRONCHIAL ASTHMA: PROPER CHOICE |
|
| Vol 11, No 3 (2014) |
Articles |
HIGH-DOSE SUBLINGUAL ALLERGEN IMMUNOTHERAPY: ADVISABILITY AND SAFETY |
|
| Vol 11, No 1 (2014) |
Articles |
Drug allergy. Recommendations for clinicians (Part 3) |
|
| Vol 10, No 4 (2013) |
Articles |
Global burden of allergy |
|
| Vol 11, No 5 (2014) |
Articles |
EXPERT MEETING CONSENSUS RESOLUTION ON NOVEL APPROACHES IN THE TREATMENT OF IDIOPATHIC URTICARIA. MOSCOW, MAY 30, 2014 |
|
